Case-control study of the parkin gene in early-onset Parkinson disease.
about
Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation updateLinking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD)Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson diseaseA comprehensive analysis of deletions, multiplications, and copy number variations in PARK2Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein.Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method.Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutationsAnalysis of Dosage Mutation in PARK2 among Korean Patients with Early-Onset or Familial Parkinson's DiseaseGenotator: a disease-agnostic tool for genetic annotation of disease.A meta-analysis of the relationship of the Parkin p.Val380Leu polymorphism to Parkinson's disease.The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD studyEarly exposure to paraquat sensitizes dopaminergic neurons to subsequent silencing of PINK1 gene expression in mice.The relation between depression and parkin genotype: the CORE-PD study.Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study.Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study.Parkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and controlThe dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies.Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.Progress in the pathogenesis and genetics of Parkinson's disease.Genetic insights into sporadic Parkinson's disease pathogenesis.Second mutation in PARK2 is absent in patients with sporadic Parkinson's disease and heterozygous exonic deletions/duplications in parkin gene.Twenty years since the discovery of the parkin gene.Amyloid Precursor Protein (APP) May Act as a Substrate and a Recognition Unit for CRL4CRBN and Stub1 E3 Ligases Facilitating Ubiquitination of Proteins Involved in Presynaptic Functions and NeurodegenerationSelf-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease.Phenotype analysis in patients with early onset Parkinson's disease with and without parkin mutations.Phase determination using chromosomal microarray and fluorescence in situ hybridization in a patient with early onset Parkinson disease and two deletions in PRKN.Heterozygote carriers for CNVs inPARK2are at increased risk of Parkinson's disease
P2860
Q22252904-077FDC2E-EB98-47E1-A107-0BB6EA00219BQ26752685-BB9CA83D-B06A-4E84-9BD3-7DE0C4554438Q30483458-DFE75F93-8ED7-4868-8197-1748C1DDAF48Q30497782-62A49591-1FAD-4870-8664-339508E54CB2Q33577056-05F01796-9404-4A1B-974B-3140A216689EQ33721033-2A2F2970-6E93-44FD-9434-44500D736ACEQ33771544-08AA2964-81CC-4CC7-9D6F-BFEA5438640CQ33911698-23AD7331-3D6C-4357-8F0A-9EC4A99F8354Q34344661-16DEB8F7-BB0C-4AFA-8568-A07FB38D0B17Q34597756-F7926C50-E175-473B-9557-A049A7D9A763Q35054613-CDD89B2E-88E7-4C12-AFAF-B01EF4D34F71Q35479978-B746919F-251A-40D3-BA9C-03B0F0FDF6C1Q35566358-FB8C86EC-AE10-4AE6-9482-B435521DE95FQ35897974-FB907159-CF29-45BA-843E-01938E437D6BQ35898027-1820C160-D797-440B-BFD7-194583C824F3Q36005602-3676A4CA-0CD9-4BFE-93F0-22945F7AB303Q36617539-82BC8AC9-E157-4767-8AEB-E7DA49187685Q36709957-C310B2FF-9636-4F9D-8A39-EED7ECD8AF69Q36761674-86229DC9-E9FB-48B9-BAB4-DE4476E9DABDQ37143657-77DEF3ED-0BBE-4031-A626-8BE518B7A027Q37583402-6E9EA84E-D25D-4D95-B4DC-7B7A805DB4A8Q39230378-B0F19CEB-6740-442F-9BC1-BE3A80B64995Q39377582-9F1BA1F5-39CD-4306-88C3-B72DF35DCFEDQ41045804-69D8B8C8-88A1-4907-A7D5-F2FAE65E0C90Q42010008-51B3BB27-4DF0-47CD-AE3B-DCE8EE736252Q44244839-FFE0BF6B-1BCF-4862-B108-201169194AD6Q55497857-3F04CE7A-D438-49EE-83AD-601C2AA6138DQ57309405-AEBAFA76-4E3C-4AC0-8F94-308677BC9571
P2860
Case-control study of the parkin gene in early-onset Parkinson disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Case-control study of the parkin gene in early-onset Parkinson disease.
@en
Case-control study of the parkin gene in early-onset Parkinson disease.
@nl
type
label
Case-control study of the parkin gene in early-onset Parkinson disease.
@en
Case-control study of the parkin gene in early-onset Parkinson disease.
@nl
prefLabel
Case-control study of the parkin gene in early-onset Parkinson disease.
@en
Case-control study of the parkin gene in early-onset Parkinson disease.
@nl
P2093
P50
P1433
P1476
Case-control study of the parkin gene in early-onset Parkinson disease.
@en
P2093
Blair Ford
Cheryl Waters
Eric Karlins
Helen Mejia-Santana
Howard Andrews
Juliette Harris
Karen Marder
Lorraine N Clark
Lucien J Cote
Shehla Afridi
P304
P356
10.1001/ARCHNEUR.63.4.548
P577
2006-04-01T00:00:00Z